1. Home
  2. RVPHW vs TBLAW Comparison

RVPHW vs TBLAW Comparison

Compare RVPHW & TBLAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPHW
  • TBLAW
  • Stock Information
  • Founded
  • RVPHW N/A
  • TBLAW N/A
  • Country
  • RVPHW United States
  • TBLAW Israel
  • Employees
  • RVPHW 15
  • TBLAW 1900
  • Industry
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • TBLAW Computer Software: Programming Data Processing
  • Sector
  • RVPHW Health Care
  • TBLAW Technology
  • Exchange
  • RVPHW Nasdaq
  • TBLAW Nasdaq
  • Market Cap
  • RVPHW N/A
  • TBLAW N/A
  • IPO Year
  • RVPHW 2018
  • TBLAW N/A
  • Fundamental
  • Price
  • RVPHW $0.12
  • TBLAW $0.12
  • Analyst Decision
  • RVPHW
  • TBLAW
  • Analyst Count
  • RVPHW 0
  • TBLAW 0
  • Target Price
  • RVPHW N/A
  • TBLAW N/A
  • AVG Volume (30 Days)
  • RVPHW N/A
  • TBLAW N/A
  • Earning Date
  • RVPHW N/A
  • TBLAW N/A
  • Dividend Yield
  • RVPHW N/A
  • TBLAW N/A
  • EPS Growth
  • RVPHW N/A
  • TBLAW N/A
  • EPS
  • RVPHW N/A
  • TBLAW N/A
  • Revenue
  • RVPHW N/A
  • TBLAW N/A
  • Revenue This Year
  • RVPHW N/A
  • TBLAW N/A
  • Revenue Next Year
  • RVPHW N/A
  • TBLAW N/A
  • P/E Ratio
  • RVPHW N/A
  • TBLAW N/A
  • Revenue Growth
  • RVPHW N/A
  • TBLAW N/A
  • 52 Week Low
  • RVPHW N/A
  • TBLAW N/A
  • 52 Week High
  • RVPHW N/A
  • TBLAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVPHW N/A
  • TBLAW N/A
  • Support Level
  • RVPHW N/A
  • TBLAW N/A
  • Resistance Level
  • RVPHW N/A
  • TBLAW N/A
  • Average True Range (ATR)
  • RVPHW 0.00
  • TBLAW 0.00
  • MACD
  • RVPHW 0.00
  • TBLAW 0.00
  • Stochastic Oscillator
  • RVPHW 0.00
  • TBLAW 0.00

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About TBLAW Taboola.com Ltd. Warrant

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.

Share on Social Networks: